A detailed history of Northcape Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Northcape Wealth Management, LLC holds 8,840 shares of AMGN stock, worth $2.34 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
8,840
Previous 3,078 187.2%
Holding current value
$2.34 Million
Previous $961,000 196.36%
% of portfolio
0.94%
Previous 0.35%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$309.38 - $337.38 $1.78 Million - $1.94 Million
5,762 Added 187.2%
8,840 $2.85 Million
Q2 2024

Jul 25, 2024

BUY
$262.75 - $319.31 $335,269 - $407,439
1,276 Added 70.81%
3,078 $961,000
Q1 2024

Apr 30, 2024

SELL
$268.87 - $324.56 $42,750 - $51,605
-159 Reduced 8.11%
1,802 $512,000
Q4 2023

Feb 05, 2024

SELL
$255.7 - $288.46 $67,760 - $76,441
-265 Reduced 11.9%
1,961 $564,000
Q3 2023

Nov 06, 2023

SELL
$218.65 - $271.46 $40,450 - $50,220
-185 Reduced 7.67%
2,226 $598,000
Q2 2023

Aug 07, 2023

SELL
$214.27 - $253.37 $6,213 - $7,347
-29 Reduced 1.19%
2,411 $535,000
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $336,878 - $410,598
1,492 Added 157.38%
2,440 $589,000
Q4 2022

Feb 07, 2023

SELL
$229.03 - $291.01 $2 Million - $2.54 Million
-8,735 Reduced 90.21%
948 $248,000
Q3 2022

Nov 08, 2022

BUY
$224.46 - $253.15 $1.79 Million - $2.02 Million
7,991 Added 472.28%
9,683 $2.18 Million
Q2 2022

Aug 09, 2022

SELL
$230.71 - $256.74 $1.85 Million - $2.05 Million
-8,004 Reduced 82.55%
1,692 $412,000
Q1 2022

Apr 18, 2022

BUY
$219.27 - $242.57 $1.75 Million - $1.94 Million
7,978 Added 464.38%
9,696 $2.35 Million
Q4 2021

Feb 09, 2022

BUY
$198.88 - $227.6 $341,675 - $391,016
1,718 New
1,718 $387,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Northcape Wealth Management, LLC Portfolio

Follow Northcape Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northcape Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northcape Wealth Management, LLC with notifications on news.